Looking for a naltrexone? Not a problem!
Discreet Package
Low Prices
24/7/365 Customer Support
100% Satisfaction Guaranteed.
>>> ENTER SITE <<<
Tags:
The FDA announced the approval of a new weight loss drug on Sept. 11, 2014. The drug name is Contrave. Using two separate drugs to shed weight can be very effective you can find combinations before the FDA now awaiting approval. When dealing with weight reduction and the individuals who go through it one should err on the side of caution and permit the FDA do its job and demand some study be done in order that the public is aware of the side effects and perils associated with the medications before we bring them. Keep in mind that drug companies will be in business to generate money and that they would say anything to keep people on the medications. Researchers found that participants taking this drug to get a year, dropped excess weight within 4 weeks and have kept the extra weight off during the entire 56 weeks with the study. Contrave is a combination with the drugs naltrexone and bupropion, which generally seems to reflect a whole new trend of weight-loss drugs which might be made up of several active ingredient, which might make them far better and safer. Combo-pilling may be the newest fad or in addition to this the newest ahead under scrutiny and therefore it is just more publicly known lately, comb-pilling for weight loss has been around since the eighties. The biggest reason that by using a combination of pills is now popular may be the fact that at the time of right now there aren't any long term prescription diet pills that have been licensed by the FDA aside from orlistat. The truly disturbing part is the fact that doctors are prescribing these combinations of medications and some of the combinations are actually rejected or have yet to be licensed by the FDA. Seizures are a side effect with Contrave and mustn't be taken in people who have seizure disorders. The drug can also raise blood pressure levels and pulse rate, and shouldn't be used in those with a history of heart attack or stroke in the earlier six months. Blood pressure and pulse should also be measured before beginning the drug and throughout therapy with the drug. The FDA also warned that Contrave can raise hypertension and heart rate and must not used in patients with uncontrolled high hypertension, as well as by anyone with heart-related and cerebrovascular (circulation dysfunction impacting the brain) disease. Patients which has a history of heart attack or stroke in the previous six months, life-threatening arrhythmias, or congestive heart failure were excluded from the clinical trials. Those taking Contrave must have their heart-rate and pulse monitored regularly. In addition, since the compound includes bupropion, Contrave comes having a boxed warning to alert physicians and patients on the increased chance of suicidal thoughts and behaviors associated with antidepressant drugs. The warning also notes that serious neuropsychiatric events are actually reported in patients taking bupropion for stopping smoking. New UCLA study on smokers with mental, drug, and alcohol problems